Nanologica AB (publ) (NICA.ST)

SEK 0.84

(0.48%)

Long Term Debt Summary of Nanologica AB (publ)

  • Nanologica AB (publ)'s latest annual long term debt in 2023 was 136 Thousand SEK , down -79.58% from previous year.
  • Nanologica AB (publ)'s latest quarterly long term debt in 2024 Q1 was 1000.00 SEK , down 0.0% from previous quarter.
  • Nanologica AB (publ) reported annual long term debt of 666 Thousand SEK in 2022, down -85.81% from previous year.
  • Nanologica AB (publ) reported annual long term debt of 4.69 Million SEK in 2021, down -42.27% from previous year.
  • Nanologica AB (publ) reported quarterly long term debt of 97 Thousand SEK for 2024 Q2, down 0.0% from previous quarter.
  • Nanologica AB (publ) reported quarterly long term debt of 535 Thousand SEK for 2023 Q1, down -19.67% from previous quarter.

Annual Long Term Debt Chart of Nanologica AB (publ) (2023 - 2012)

Historical Annual Long Term Debt of Nanologica AB (publ) (2023 - 2012)

Year Long Term Debt Long Term Debt Growth
2023 136 Thousand SEK -79.58%
2022 666 Thousand SEK -85.81%
2021 4.69 Million SEK -42.27%
2020 8.12 Million SEK 26.72%
2019 6.41 Million SEK 302.16%
2018 1.59 Million SEK -41.48%
2017 2.72 Million SEK -28.2%
2016 3.79 Million SEK 269.85%
2015 1.02 Million SEK -29.46%
2014 1.45 Million SEK 0.0%
2013 - SEK 0.0%
2012 - SEK 0.0%

Peer Long Term Debt Comparison of Nanologica AB (publ)

Name Long Term Debt Long Term Debt Difference
Alzinova AB (publ) 800 Thousand SEK 83.0%
Amniotics AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK 86.4%
BioArctic AB (publ) 2.15 Million SEK 93.68%
Calliditas Therapeutics AB (publ) 939.5 Million SEK 99.986%
Genovis AB (publ.) 74.8 Million SEK 99.818%
LIDDS AB (publ) - SEK -Infinity%
Magle Chemoswed Holding AB (publ) 32.58 Million SEK 99.583%
OncoZenge AB (publ) - SEK -Infinity%
Saniona AB (publ) 65.23 Million SEK 99.792%
Simris Alg AB (publ) 90.74 Million SEK 99.85%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Active Biotech AB (publ) 3 Million SEK 95.467%
Camurus AB (publ) 13.61 Million SEK 99.001%
Cantargia AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Mendus AB (publ) 850 Thousand SEK 84.0%
Kancera AB (publ) - SEK -Infinity%
Karolinska Development AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK 92.277%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xbrane Biopharma AB (publ) 112.89 Million SEK 99.88%
Xintela AB (publ) - SEK -Infinity%
Ziccum AB (publ) 286 Thousand SEK 52.448%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
Isofol Medical AB (publ) - SEK -Infinity%
Xspray Pharma AB (publ) 31.94 Million SEK 99.574%
CombiGene AB (publ) - SEK -Infinity%
Diamyd Medical AB (publ) 30.67 Million SEK 99.557%
Intervacc AB (publ) 142 Thousand SEK 4.225%
Alligator Bioscience AB (publ) 7.51 Million SEK 98.191%
Sprint Bioscience AB (publ) - SEK -Infinity%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 24.51 Million SEK 99.445%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Biovica International AB (publ) 4.29 Million SEK 96.834%
Spago Nanomedical AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK 67.925%
Egetis Therapeutics AB (publ) 103.4 Million SEK 99.868%
2cureX AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 844.9 Million SEK 99.984%
Cyxone AB (publ) 74 Thousand SEK -83.784%
ExpreS2ion Biotech Holding AB (publ) 1.43 Million SEK 90.529%
Biosergen AB - SEK -Infinity%
SynAct Pharma AB 58 Thousand SEK -134.483%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
BioInvent International AB (publ) 14.53 Million SEK 99.064%
Stayble Therapeutics AB (publ) 850 Thousand SEK 84.0%
Oncopeptides AB (publ) 106.48 Million SEK 99.872%
Pila Pharma AB (publ) - SEK -Infinity%
Ascelia Pharma AB (publ) 176 Thousand SEK 22.727%
Diagonal Bio AB (publ) - SEK -Infinity%